TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›SONM
SONM logo

SONM

DNA X, Inc.

Next earnings Aug 6, 2026

Last earnings +4.2% on 2026-05-20

Avoid
$3.75
▼ -33.39%
$3.75▼ -85.33%
over 1Y
L $2.75H $25.56
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-33.4%
1W-20.6%
1M-35.3%
3M+3.3%
YTD+30.2%
1Y-85.3%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
F
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Short (<3mo)
Street · 7 analysts
Buy

Going-concern shell that sold its only real business and bet the remains on an unproven crypto platform — negative equity, near-empty till.

Cash & equivalents $1.30M · FY2025

This is not the company its P/S of 0.1 implies. The revenue history ($50.9M FY2024, down 45.6%) belongs entirely to the legacy Sonim phone/hotspot business, which management sold to Pace Car Acquisition LLC in January 2026 for $15M and now reports as a discontinued operation for all periods. What remains is DNA X, a cryptocurrency trading platform acquired December 15, 2025 that only became operational in November 2025 — so the 'company' you are buying has essentially no revenue track record, and the cheap-looking sales multiple is an artifact of businesses that no longer exist. The filing is blunt: 'there is substantial doubt regarding the Company's ability to continue as a going concern.'

The balance sheet corroborates the warning. Stockholders' equity is negative $7.96M against a $304M accumulated deficit; cash fell 75.6% to just $1.30M while operating activities burned $23.5M in FY2025. Current liabilities ($48.0M) exceed current assets ($28.9M) by roughly $19M, and both current and long-term debt lines exploded (+3,345% and +1,299%). The company stayed alive only by selling stock — $13.7M via ATM and private placements plus $5.1M of promissory notes — and has a Chardan ChEF committed-equity facility standing by to sell still more. With 1.49M shares (post a 1-for-18 reverse split) and a $5.58M market cap, holders face relentless dilution against a $23.5M-a-year burn rate on a platform running 'on a limited basis.'

Is SONM a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bear put spread (caution)~30d expiry
  • Long put 4 @ ~0.88 est
  • Short put 3.5 @ ~0.59 est
debit $29max +$21max −$29BE 3.71

AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$54.6M$69.8M$93.6M$50.9M—
Gross profit$6.41M$11.6M$19.3M$9.92M—
Operating income-$38.0M-$14.3M$513K-$3.10M-$5.41M
Net income-$38.6M-$14.1M-$90.0K-$33.6M-$20.7M
Diluted EPS—-$0.49-$0.02-$128.37-$28.58
Net margin-70.8%-20.2%-0.1%-66.1%—

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$14.4M
EV / EBITDA—
EV / Sales0.3
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-370.1%
FCF yield-425.3%

Quality & risk

ROIC (est.)—
Free cash flow-$23.7M
Total debt$10.1M
Net cash-$8.83M
Altman Z-Score-9.41 distress
Piotroski F-Score2/9

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-76.5%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Material agreement2026-07-02

    New financing pact with unregistered share sale + charter changes to holder rights

  2. 8-K Agreement terminated2026-06-04

    Terminated a material definitive agreement

  3. 8-K Delisting notice2026-05-27

    Nasdaq delisting notice plus new debt obligation and further unregistered share sales

  4. 8-K Earnings results2026-05-20

    Q1 10-Q: pivot to DNA X crypto trading, phone unit now discontinued operations

  5. 10-Q Quarterly report2026-05-20

    Q1 10-Q: pivot to DNA X crypto trading, phone unit now discontinued operations

  6. NT 10-Q Late filing notice2026-05-15

    Filed NT 10-Q late-filing notice for the Q1 quarterly report

  7. 8-K Auditor change2026-04-30

    Amended FY2025 10-K (10-K/A) to add omitted disclosures

  8. 10-K/A Restated periodic report2026-04-30

    Amended FY2025 10-K (10-K/A) to add omitted disclosures

  9. 8-K Earnings results2026-04-15

    FY2025 10-K flags going-concern doubt; sold phone unit, pivoted to crypto

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-292026-07-02open ↗EFFECTFiling2026-06-11open ↗POS AMFiling2026-06-08open ↗8-KPeriod ending 2026-05-292026-06-04open ↗8-KPeriod ending 2026-05-202026-05-27open ↗10-QPeriod ending 2026-03-312026-05-20open ↗8-KPeriod ending 2026-05-202026-05-20open ↗NT 10-QPeriod ending 2026-03-312026-05-15open ↗SCHEDULE 13G/AFiling2026-05-15open ↗10-K/APeriod ending 2025-12-312026-04-30open ↗8-KPeriod ending 2026-04-272026-04-30open ↗10-KPeriod ending 2025-12-312026-04-15open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueA+
GrowthC
ProfitabilityF
Financial healthF
MomentumF
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Liabilities below 2× equity
2.7552-week16.87
Revenue
$50.9M
-45.6% YoY
Net margin
-40.6%
ROE
—
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$50.9M-45.6%
Net income-$20.7M+38.6%
Gross profit$9.92M-48.7%
Operating income-$5.41M-74.4%
Diluted EPS-$28.58+77.7%
Cash & equivalents$1.30M-75.6%
Total assets$43.9M+10.5%
Total liabilities$50.6M+11.4%
Stockholders' equity-$7.96M-39.6%
Gross: 19.5%Op.: -10.6%L/E: -6.36x

Frequently asked

Is DNA X, Inc. (SONM) a buy?
SONM currently carries a Avoid rating with 5/5 conviction, derived from its latest SEC filings. Going-concern shell that sold its only real business and bet the remains on an unproven crypto platform — negative equity, near-empty till.
What is DNA X, Inc.'s quality score?
SONM scores 38.2/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001178697, latest 10-Q filed 2026-05-20) · EODHD · Proprietary analysis · as of 7/4/2026, 9:57:29 AM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 5:57 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-02-09
Crolius Clayton
Chief Financial Officer
Award35.0K
2026-02-09
MULICA MICHAEL C
Acting CEO
Award50.0K
2025-06-30
LYTTON LAURENCE W
10% owner
Sell401K @ $1.39$557K
2025-06-26
LYTTON LAURENCE W
10% owner
Sell466K @ $1.50$700K
2025-04-23
Becher Charles
See Remarks
Sell31.3K @ $1.45$45.4K
2025-04-23
MULICA MICHAEL C
Director
Sell27.8K @ $1.45$40.3K
2025-04-23
Crolius Clayton
Chief Financial Officer
Sell11.6K @ $1.45$16.9K

Earnings history

beat/miss · move
2026-05-20—▼ -7.40%8-K ↗
2026-04-15—▲ +4.14%8-K ↗
2025-10-31—▼ -8.42%8-K ↗
2025-08-08—▼ -3.28%8-K ↗
2025-05-12—▲ +4.93%8-K ↗
2025-03-31—▼ -19.28%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score38 vs 67
Revenue growth-45.6% vs 7.5%
Net margin-40.6% vs 10.0%
Return on equity— vs 12.0%
P/E— vs 26.2